Cargando…
Costs and Benefits of Diagnosing Familial Breast Cancer
Based on results from our surveillance program for women at risk for inherited breast cancer, we have calculated cost per year earned. Norwegian National Insurance Service reimbursement fees were used in the calculations. The calculated costs are based on empirical figures for expanding already esta...
Autores principales: | Heimdal, Ketil, Mæhle, Lovise, Møller, Pål |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851967/ https://www.ncbi.nlm.nih.gov/pubmed/10595273 http://dx.doi.org/10.1155/1999/751892 |
Ejemplares similares
-
BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations
por: Borg, Åke, et al.
Publicado: (1999) -
Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer
por: Møller, Pål, et al.
Publicado: (1999) -
Use of Cytology to Diagnose Inherited Breast Cancer
por: Møller, Pål, et al.
Publicado: (1999) -
Germline PTEN mutations are rare and highly penetrant
por: Rustad, Cecilie F, et al.
Publicado: (2006) -
Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations
por: Reichelt, Jon G., et al.
Publicado: (1999)